Aron Goldhirsch
- Oncology top 0.5%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Pathology and Forensic Medicine top 1%
- Molecular Biology top 10%
- Co-authors
- Giuseppe CuriglianoRichard D. GelberCarmen CriscitielloHans-Jörg SennJohn H. GlickWilliam C. WoodFranco NolèMaria Teresa Sandri
- Topics
- Breast Cancer Treatment Studies (67 papers)Cancer Treatment and Pharmacology (36 papers)HER2/EGFR in Cancer Research (34 papers)
- Partner nations
- ItalySwitzerlandUnited States
In The Last Decade
Aron Goldhirsch
116 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 3.4k
- Cancer Research 2.7k
- Pulmonary and Respiratory Medicine 990
- Pathology and Forensic Medicine 907
- Molecular Biology 806
Countries citing papers authored by Aron Goldhirsch
This map shows the geographic impact of Aron Goldhirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aron Goldhirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aron Goldhirsch more than expected).
Fields of papers citing papers by Aron Goldhirsch
This network shows the impact of papers produced by Aron Goldhirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aron Goldhirsch. The network helps show where Aron Goldhirsch may publish in the future.
Co-authorship network of co-authors of Aron Goldhirsch
This figure shows the co-authorship network connecting the top 25 collaborators of Aron Goldhirsch. A scholar is included among the top collaborators of Aron Goldhirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aron Goldhirsch. Aron Goldhirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence. | 1 |
| 3 | 45 | |
| 4 | 43 | |
| 5 | 13 | |
| 6 | 84 | |
| 7 | 29 | |
| 8 | 55 | |
| 9 | 38 | |
| 10 | 57 | |
| 11 | Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelinesbreakdown → | 595 |
| 12 | 90 | |
| 13 | 23 | |
| 14 | 11 | |
| 15 | 78 | |
| 16 | 19 | |
| 17 | 282 | |
| 18 | 36 | |
| 19 | 26 | |
| 20 | 13 |
About Aron Goldhirsch
Aron Goldhirsch is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 119 papers that have together received 5.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (67 papers), Cancer Treatment and Pharmacology (36 papers) and HER2/EGFR in Cancer Research (34 papers). The work is most often cited by research in Cancer Research (2.7k citations), Oncology (3.4k citations) and Pathology and Forensic Medicine (907 citations). Aron Goldhirsch has collaborated with scholars based in Italy, Switzerland and United States. Frequent co-authors include Giuseppe Curigliano, Richard D. Gelber, Carmen Criscitiello, Hans-Jörg Senn, John H. Glick, William C. Wood, Franco Nolè, Maria Teresa Sandri, Elisabetta Munzone and Lucia Gelao. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.